soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Semaglutide and Cardiovascular Outcomes in

As more people gain access to advanced medical treatments, the demand for this drug is expected to rise significantly in the country

August 2021: Ozempic Associated With Heightened Risk of Diabetic Retinopathy Study results focused on diabetic retinopathy (DR) in patients taking semaglutide found that a higher risk for DR complications were observed with semaglutide in patients with proliferative and non-proliferative DR at baseline. However, researchers do acknowledge that worsening DR can be from rapid drops in blood glucose levels from diabetic medications

Its also just pure emotional venting for me

I was having a payment issue and they fixed it for me in no time.